iNfinitesimal is a nanobiotechnology company that develops devices for targeted and controlled cellular delivery of biomolecules, drugs, nanoparticles, or other chemicals in liquid solution. Our mission is to enable precise cell access for gene editing and cellular therapies through the development of the first automated single cell transfection system leveraging proprietary NanoFountain Probe - Electroporation (NFP-E) technology licensed from Northwestern University.